US Stock MarketDetailed Quotes
Prelude Therapeutics (PRLD)
- 3.370
- -0.440-11.55%
Close Mar 12 16:00 ET
- 3.220
- -0.150-4.45%
Post 18:17 ET
212.32MMarket Cap-2.61P/E (TTM)
3.810High3.330Low278.62KVolume3.710Open3.810Prev Close986.97KTurnover1.70%Turnover RatioLossP/E (Static)63.00MShares4.22052wk High3.09P/B55.27MFloat Cap0.61052wk Low--Dividend TTM16.40MShs Float95.375Historical High--Div Yield TTM12.60%Range %0.610Historical Low3.542Avg Price1Lot Size
Prelude Therapeutics (PRLD) Key Financial Indicators
PRLD Earnings per Share (EPS)
According to the latest financial report of Prelude Therapeutics, the latest earnings per share (TTM) for the company is -0.26. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
PRLD Free Cash Flow (FCF)
Interested in knowing about Prelude Therapeutics's free cash flow? The latest report shows it as -19.12M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
PRLD Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Prelude Therapeutics shows that the company's current ratio is 3.21, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
PRLD Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Prelude Therapeutics, the quick ratio is 3.02, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
PRLD Return on Equity (ROE)
Want to learn more about the financial health of Prelude Therapeutics? The latest ROE figure is -29.36%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
PRLD Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Prelude Therapeutics, the total asset return on investment (ROA) is -18.82%.
Currency: USD
Quarterly
Loading...
PRLD Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Prelude Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
PRLD Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Prelude Therapeutics, the net profit margin is -303.46%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...